204 related articles for article (PubMed ID: 20551266)
21. Over-expression of topoisomerase IIalpha is related to the grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict prognosis in cervical cancer or HPV clearance after cone treatment.
Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Syrjänen SM; Favalli C; Syrjänen K;
Int J Gynecol Pathol; 2006 Oct; 25(4):383-92. PubMed ID: 16990717
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of 14-3-3sigma (Stratifin) is associated with high-grade CIN and high-risk human papillomavirus (HPV) at baseline but does not predict outcomes of HR-HPV infections or incident CIN in the LAMS study.
Syrjänen S; Naud P; Sarian L; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Costa S; Syrjänen K
Am J Clin Pathol; 2010 Feb; 133(2):232-40. PubMed ID: 20093232
[TBL] [Abstract][Full Text] [Related]
23. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
[TBL] [Abstract][Full Text] [Related]
24. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies.
Nieh S; Chen SF; Chu TY; Lai HC; Lin YS; Fu E; Gau CH
Gynecol Oncol; 2005 Apr; 97(1):35-40. PubMed ID: 15790434
[TBL] [Abstract][Full Text] [Related]
25. High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing.
Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Garcia S; Campo E; Pahisa J; Ordi J
Am J Obstet Gynecol; 2007 Oct; 197(4):359.e1-6. PubMed ID: 17714678
[TBL] [Abstract][Full Text] [Related]
26. Cell cycle regulators p105, p107, Rb2/p130, E2F4, p21CIP1/WAF1, cyclin A in predicting cervical intraepithelial neoplasia, high-risk human papillomavirus infections and their outcome in women screened in three new independent states of the former Soviet Union.
Santopietro R; Shabalova I; Petrovichev N; Kozachenko V; Zakharova T; Pajanidi J; Podistov J; Chemeris G; Sozaeva L; Lipova E; Tsidaeva I; Ivanchenko O; Pshepurko A; Zakharenko S; Nerovjna R; Kljukina L; Erokhina O; Branovskaja M; Nikitina M; Grunberga V; Grunberg A; Juschenko A; Cintorino M; Tosi P; Syrjänen K; Syrjänen S
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1250-6. PubMed ID: 16835319
[TBL] [Abstract][Full Text] [Related]
27. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
Ovestad IT; Dalen I; Hansen E; Loge JL; Dybdahl BM; Dirdal MB; Moltu P; Berland JM
Cancer Cytopathol; 2017 Apr; 125(4):283-291. PubMed ID: 27918650
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.
Yang W; Song Y; Lu YL; Sun JZ; Wang HW
Immunology; 2013 Aug; 139(4):513-22. PubMed ID: 23521696
[TBL] [Abstract][Full Text] [Related]
29. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus typing and viral gene expression analysis for the triage of women with abnormal results from papanicolaou test smears to colposcopy.
Antonishyn NA; Horsman GB; Kelln RA; Severini A
Arch Pathol Lab Med; 2009 Oct; 133(10):1577-86. PubMed ID: 19792047
[TBL] [Abstract][Full Text] [Related]
31. Comparison of cytology, colposcopy, HPV typing and biomarker analysis in cervical neoplasia.
Adamopoulou M; Kalkani E; Charvalos E; Avgoustidis D; Haidopoulos D; Yapijakis C
Anticancer Res; 2009 Aug; 29(8):3401-9. PubMed ID: 19661364
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer.
Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):223-31. PubMed ID: 17098349
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer.
Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Syrjänen S; Favalli C; Syrjänen K
Diagn Cytopathol; 2006 Nov; 34(11):739-48. PubMed ID: 17041957
[TBL] [Abstract][Full Text] [Related]
34. FHIT and C-MYC expression in cervical histology and cytology as biomarkers for detecting high-grade intraepithelial neoplasia in human papillomavirus-positive women.
Yang F; Cui Z; Liao Y; Tian R; Fan W; Jin Z; Hu Z; Yao S
Cancer Biomark; 2020; 27(3):303-312. PubMed ID: 31771040
[TBL] [Abstract][Full Text] [Related]
35. Alterations in human papillomavirus-related biomarkers after treatment of cervical intraepithelial neoplasia.
Valasoulis G; Koliopoulos G; Founta C; Kyrgiou M; Tsoumpou I; Valari O; Martin-Hirsch P; Daponte A; Karakitsos P; Paraskevaidis E
Gynecol Oncol; 2011 Apr; 121(1):43-8. PubMed ID: 21216451
[TBL] [Abstract][Full Text] [Related]
36. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
Ki EY; Park JS; Lee A; Kim TJ; Jin HT; Seo YB; Gen Y; Park MY; Lee SJ
Int J Med Sci; 2019; 16(8):1096-1101. PubMed ID: 31523171
[No Abstract] [Full Text] [Related]
37. Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1-2 lesions.
Li Y; Liu J; Gong L; Sun X; Long W
Virol J; 2019 Oct; 16(1):117. PubMed ID: 31619262
[TBL] [Abstract][Full Text] [Related]
38. In vivo cyclin E expression as a marker for early cervical neoplasia.
Quade BJ; Park JJ; Crum CP; Sun D; Dutta A
Mod Pathol; 1998 Dec; 11(12):1238-46. PubMed ID: 9872657
[TBL] [Abstract][Full Text] [Related]
39. PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia.
Fambrini M; Penna C; Pieralli A; Bussani C; Fallani MG; Andersson KL; Scarselli G; Marchionni M
Gynecol Oncol; 2008 Apr; 109(1):59-64. PubMed ID: 18255129
[TBL] [Abstract][Full Text] [Related]
40. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].
Bekkers RL; Hanselaar AG; Melchers WJ; van Schaik JH; Boonstra H; Massuger LF
Ned Tijdschr Geneeskd; 2003 Feb; 147(7):302-6. PubMed ID: 12622008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
